Virt-Advance Prenatal Softgels (Virtus Pharmaceuticals) – API Import Alert (2016)
Class III: A situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences
Class III recall indicates unlikely adverse health consequences.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Virt-Advance Prenatal/Postnatal Softgels, Prescription Folic Acid Containing Dietary Supplement, packaged in 90-count bottle, Rx only, Made in Canada, NDC 76439-357-90
Brand
VIRTUS PHARMACEUTICALS OPCO II L
Lot Codes / Batch Numbers
Lots #: 41505136 Exp. Date 5/30/2017 and 41605134 Exp. date 4/30/2018
Products Sold
Lots #: 41505136 Exp. Date 5/30/2017 and 41605134 Exp. date 4/30/2018
VIRTUS PHARMACEUTICALS OPCO II L is recalling Virt-Advance Prenatal/Postnatal Softgels, Prescription Folic Acid Containing Dietary Supplement, pac due to cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 7, 2026